Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252833 · ClinicalTrials.gov registry record · Phase 1
Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers
A Phase 1 study, sponsored by Lotus Clinical Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04252833: Completed Phase 1 study, sponsored by Lotus Clinical Research.
NCT04252833 is a Phase 1 study that has completed, run by Lotus Clinical Research. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04252833, a Phase 1 study, has completed, sponsored by Lotus Clinical Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.
Primary Outcome
Following administration with and without food (Cmax) of oral single dose of CT-044
Interventions
- DRUG CT-044
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2020-03-16 |
| Phase | Phase 1 |
What the finished NCT04252833 record still lists
NCT04252833 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which CT-044 is the first listed.
NCT04252833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04252833 about?
NCT04252833 is a clinical study titled "Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers". This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.
What is the current status of trial NCT04252833?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2020-02-18. Estimated completion is 2020-03-16.
What interventions are being tested in trial NCT04252833?
The interventions under investigation include: CT-044 (DRUG).
Who is sponsoring clinical trial NCT04252833?
This trial is sponsored by Lotus Clinical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04252833's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI